You are currently viewing a new version of our website. To view the old version click .
Children
  • Review
  • Open Access

29 May 2025

Cerebral Palsy Link to Sensorimotor System, Cognition, Emotion and Nociplastic Pain

and
Department for Health Sciences, Medicine and Research, Faculty of Health and Medicine, Center for Health Sciences and Medicine, A-3500 Krems, Austria
*
Author to whom correspondence should be addressed.
This article belongs to the Special Issue Cerebral Palsy in Children: Improving Quality of Life and Preventing Painful Musculoskeletal Disorders

Abstract

This narrative review provides an overview of the link between the sensorimotor system, cognition, emotion and pain syndromes in persons due to deconditioning or delayed sensorimotor development, then applied to persons with cerebral palsy (CP). The brain damage that occurs before, during or even after birth pathophysiologically alters the structure and subsequent function of the sensorimotor function, which is inseparably linked to cognition, emotion, behavior and pain. This damage results in a functional developmental disorder that also affects the structure and function of the neuromatrix in a graded manner due to chronic deconditioning. It is the basis for both primary and secondary chronic degenerative diseases. This leads to an increasing prevalence of chronic pain syndromes, which may be very high in persons with CP. Thus, CP is both a disposing factor and a causal factor for nociplastic pain, defined as persistent pain arising from altered nociception without evidence of tissue or somatosensory damage. Therapy interventions are crucial to optimize movement, cognition and emotion, as well as pain reduction in persons with CP.

1. Introduction

The aim of this narrative review is to provide an overview of the link between the sensorimotor system, cognition, emotion and pain syndromes in persons due to deconditioning or delayed sensorimotor development, then specifically applied to persons with cerebral palsy (CP) that involves both factors. The sensorimotor system consists of the peripheral and central nervous systems and musculature. Depending on the level of movement abilities, it is responsible for the following: all movements with a specific cognitive performance; non-movement-specific cognitive and emotional brain functions that shape learning ability, competencies, and overall behavior; and the function of pain inhibition and pain modulation. Impairments in the sensorimotor system may occur in an individual due to several factors: due to deconditioning, due to sensorimotor developmental delay, and, most severely, due to cerebral damage before, during or even after birth. These impairments influence and determine movement and may lead to chronic degenerative diseases with chronic pain as a symptom. If symptoms worsen, nociplastic pain syndromes may develop. Nociplastic pain is defined by the International Association for the Study of Pain as persistent pain that arises from altered nociception, despite no clear evidence of actual or threatened tissue damage causing the activation of peripheral nociceptors, or evidence for disease or lesion of the somatosensory system causing the pain [1]. This demonstrates the intensive networking of the neuromatrix and the fact that both functional developmental delay due to deconditioning and structural developmental delay due to CP are each a predisposition to, and at the same time, a factor in the occurrence of cognitive and emotional behaviour modifications and pain syndromes.
In this review, the focus is on persons with CP. Pre- and perinatal or even postnatal damage to the central nervous system before the age of two is responsible for CP. The etiology is multifactorial and includes genetic, infectious or pollutant-related and more frequently vascular and ischemic factors. Damage-related inflammatory processes are also involved in its development [2,3]. Premature babies are disproportionately at risk due to the vulnerability of the vascular system [4,5] and have generally lower levels of functional and structural brain-related proteins [6]. The symptoms and consequences are highly variable depending on the site of damage in the brain and the extent of the damage. Early childhood brain damage disrupts the brain’s ability to control movement and maintain posture and balance. This is termed CP, whereby the term “cerebral” refers to the brain and “palsy” refers to the loss or impairment of motor function. CP implies a disruption of the sensorimotor and corticomotor networks and their interactions, leading to a loss of selective motor control, gross motor function, postural control and notably spasticity. The spasticity is due to the muscle volume being massively reduced and the quality of the contractile properties being reduced, thus shortening the muscles. In addition, the ability to regenerate is reduced and inflammatory processes take place.
The development of the sensory systems with their central processing structures and the correct timing of early childhood reflexes are essential elements in the maturation of sensorimotor function. Sensorimotor development is the “biological stimulator” for the development of the highest brain functions, as there is no sensorimotor development without cognitive and emotional functions and performance. For example, from a sensorimotor perspective, the vestibulo-ocular and vestibulo-spinal reflexes ensure that the positioning of the head is controlled and thus provide the prerequisite for the visual system to be able to depict the environment in a stable manner and for the brain to be able to process the information [7,8]. It also enables the body to straighten up, allowing for essential functional elements of sensorimotor coordination and postural regulation to develop balance and precision of movement. Infants who cannot maintain balance and are placed in passive and premature upright positions in the first year of life were shown to have impaired quality of postural, coordination, and reflex functions in adolescence [9]. In addition to the importance of movement, there is the interconnection between the sensorimotor system and the neuronal networks for memory and emotion [10]. The brain does not have a pain center, but there are pain components involving the highest functional levels: sensory-discriminative, cognitive-evaluative and affective-emotional. The development of sensorimotor functions is coupled with pain inhibition and pain modulation to form a functional unit in healthy individuals [11]. Pronounced early childhood damage to the brain, combined with early childhood sensorimotor developmental delays, can be regarded as factors for the development of nociplastic pain syndromes. The very high prevalence of chronic pain in persons with CP speaks for this [12,13].
The following sections of this review describe the interrelationships between brain structure, sensory-motor function, cognition, emotion and pain syndromes.

8. CP Damage to the Brain Structure and Pathogenesis of Chronic Pain Syndromes

Early structural disorders caused by an inadequate O2 supply or other factors directly affect the sensorimotor and subsequently the cognitive-emotional development in pathophysiological terms. The cerebral abnormalities and dysfunctions characterize the adapted deficient peripheral myo-fascial-skeletal structures. This affects the contractile function for mobility. With this development, the periphery also becomes a generator of nociceptive afferents that the brain has to process.
Figure 6 provides an overview of the pathological processes in CP. An inadequate blood supply causes primary structural disturbances, the timing and extent of which determine development. Damage to the structures of the somatosensory and corticomotor networks [39] and their interactions leads to loss of selective motor and postural control [71,72] and causes spasticity. Sensorimotor disorders include intellectual, cognitive, emotional functions and communicative behavior [73,74]. Pathological cerebral connectivity also causes deficits in the hypothalamus–pituitary–liver axis (GH–IGF-1; not considered in detail), resulting in growth disorders [75,76]. Muscle mass is qualitatively and quantitatively restricted, and the ability to regenerate is reduced [8,61,62]. Generalized inflammatory processes also occur, and sarcopenia develops at an early stage [13,77,78]. The sensorimotor limitations cause secondary physical inactivity, whereby the already functionally underdeveloped structures develop an ‘extended’ deconditioning.
Figure 6. Pathological processes.
The primary disorders are both a predisposing and causal factor of a deficient pain inhibition, and as a result, premature sensitization develops in the periphery and brain, so that persons with CP experience chronic pain.

9. Conclusions

Physical, sensorimotor, cognitive-emotional and anti-nociceptive functions depend on the structural and functional integrity of the nervous system. This integrity is the result of the physiological or pathophysiological development of sensorimotor function. An initially healthy nervous system can be impaired at all stages of life by chronic physical inactivity. Inactivity leads to deconditioning as the basis for chronic degenerative diseases, which are initially the cause of chronic secondary pain and from which chronic primary nociplastic pain may develop. In CP, damage to the brain and delayed sensorimotor function directly affect cognition and emotional regulation. This results in children experiencing issues in learning, behavior, language development and school performance since sensorimotor function and high-performing cerebral abilities are interlinked and interdependent. These factors combined result in a secondary physical inactivity, which may turn into deconditioning. Therapy interventions promote development and counteract the deconditioning process. This is crucial to improve movement, cognition and emotional control as well as the reduction of pain syndromes in children and adults with CP.

Author Contributions

Conceptualization, W.L. and M.S.; methodology, W.L.; writing—original draft preparation, W.L.; writing—review and editing, M.S.; visualization, W.L. and M.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable as the review of the material is accessible through open access.

Data Availability Statement

No new data were created.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
CPCerebral palsy
fMRIFunctional magnetic resonance imaging
CNSCentral nervous system
SMSSensorimotor system

References

  1. Slater, H.; Hush, J. Pain Terminology: Introduction of a Third Clinical Descriptor. Pain Terminol. 2018, 3, 7–8. [Google Scholar]
  2. Mineyko, A.; Nettel-Aguirre, A.; de Jesus, P.; Benseler, S.; Yusuf, K.; Narendran, A.; Kirton, A. Association of neonatal inflammatory markers and perinatal stroke subtypes. Neurology 2020, 95, e1163–e1173. [Google Scholar] [CrossRef] [PubMed]
  3. Goracke-Postle, C.J.; Burkitt, C.C.; Panoskaltsis-Mortari, A.; Ehrhardt, M.; Wilcox, G.L.; Graupman, P.; Partington, M.; Symons, F.J. Expression of and correlational patterns among neuroinflammatory, neuropeptide, and neuroendocrine molecules from cerebrospinal fluid in CP. BMC Neurol. 2021, 21, 384. [Google Scholar] [CrossRef] [PubMed]
  4. Lien, R. Neurocritical care of premature infants. Biomed. J. 2020, 43, 259–267. [Google Scholar] [CrossRef]
  5. Özek, E.; Kersin, S.G. Intraventricular hemorrhage in preterm babies. Turk Pediatri Ars. 2020, 55, 215–221. [Google Scholar] [CrossRef]
  6. Leifsdottir, K.; Jost, K.; Siljehav, V.; Thelin, E.P.; Lassarén, P.; Nilsson, P.; Haraldsson, Á.; Eksborg, S.; Herlenius, E. The cerebrospinal fluid proteome of preterm infants predicts neurodevelopmental outcome. Front. Pediatr. 2022, 10, 921444. [Google Scholar] [CrossRef]
  7. Kobesova, A.; Kolar, P. Developmental kinesiology: Three levels of motor control in the assessment and treatment of the motor system. J. Bodyw. Mov. Ther. 2014, 18, 23–33. [Google Scholar] [CrossRef]
  8. Božanić Urbančič, N.; Battelino, S.; Vozel, D. Appropriate Vestibular Stimulation in Children and Adolescents-A Prerequisite for Normal Cognitive, Motor Development and Bodily Homeostasis—A Review. Children 2023, 11, 2. [Google Scholar] [CrossRef]
  9. Maciak, M.; Koszela, K.; Beniuk, A.; Woldańska-Okońska, M. The Assessment of Postural-Motor, Coordination, and Reflex Functions in Children and Adolescents with a History of Premature Verticalization and Ontogeny Disorders in Their First Year of Life. Children 2024, 11, 1071. [Google Scholar] [CrossRef]
  10. Dieterich, M.; Brandt, T. Central vestibular networking for sensorimotor control, cognition, and emotion. Curr. Opin. Neurol. 2024, 37, 74–82. [Google Scholar] [CrossRef]
  11. Laube, W. Sensomotorik und Schmerz; Springer: Berlin/Heidelberg, Germany, 2020. [Google Scholar]
  12. Ostojic, K.; Paget, S.; Kyriagis, M.; Morrow, A. Acute and Chronic Pain in Children and Adolescents With CP: Prevalence, Interference, and Management. Arch. Phys. Med. Rehabil. 2020, 101, 213–219. [Google Scholar] [CrossRef]
  13. McKinnon, C.T.; Morgan, P.E.; Antolovich, G.C.; Clancy, C.H.; Fahey, M.C.; Harvey, A.R. Pain in children with dyskinetic and mixed dyskinetic/spastic CP. Dev. Med. Child Neurol. 2020, 62, 1294–1301. [Google Scholar] [CrossRef]
  14. World Health Organization. WHO Guidelines on Physical Activity and Sedentary Behaviour; World Health Organization: Geneva, Switzerland, 2020; ISBN 978-92-4-001513-5/978-92-4-001512-8. (electronic version). [Google Scholar]
  15. Pedersen, B.K. The Diseasome of Physical Inactivity and the role of myokines in muscle-fat cross talk. J. Physiol. 2009, 587, 5559–5568. [Google Scholar] [CrossRef] [PubMed]
  16. Shraim, M.A.; Massé-Alarie, H.; Farrell, M.J.; Cavaleri, R.; Loggia, M.L.; Hodges, P.W. Neuroinflammatory activation in sensory and motor regions of the cortex is related to sensorimotor function in individuals with low back pain maintained by nociplastic mechanisms: A preliminary proof-of-concept study. Eur. J. Pain 2024, 28, 1607–1626. [Google Scholar] [CrossRef] [PubMed]
  17. Safdar, A.; Tarnopolsky, M.A. Exosomes as Mediators of the Systemic Adaptations to Endurance Exercise. Cold Spring Harb. Perspect. Med. 2018, 8, a029827. [Google Scholar] [CrossRef] [PubMed]
  18. Fuller, O.K.; Whitham, M.; Mathivanan, S.; Febbraio, M.A. The Protective Effect of Exercise in Neurodegenerative Diseases: The Potential Role of Extracellular Vesicles. Cells 2020, 9, 2182. [Google Scholar] [CrossRef]
  19. Darragh, I.A.J.; O’Driscoll, L.; Egan, B. Exercise Training and Circulating Small Extracellular Vesicles: Appraisal of Methodological Approaches and Current Knowledge. Front. Physiol. 2021, 12, 738333. [Google Scholar] [CrossRef]
  20. Treede, R.D.; Rief, W.; Barke, A.; Aziz, Q.; Bennett, M.I.; Benoliel, R.; Cohen, M.; Evers, S.; Finnerup, N.B.; First, M.B.; et al. Chronic pain as a symptom or a disease: The IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain 2019, 160, 19–27. [Google Scholar] [CrossRef]
  21. Kosek, E.; Clauw, D.; Nijs, J.; Baron, R.; Gilron, I.; Harris, R.E.; Mico, J.A.; Rice, A.S.C.; Sterling, M. Chronic nociplastic pain affecting the musculoskeletal system: Clinical criteria and grading system. Pain 2021, 162, 2629–2634. [Google Scholar] [CrossRef]
  22. Nijs, J.; George, S.Z.; Clauw, D.J.; Fernández-de-Las-Peñas, C.; Kosek, E.; Ickmans, K.; Fernández-Carnero, J.; Polli, A.; Kapreli, E.; Huysmans, E.; et al. Central sensitisation in chronic pain conditions: Latest discoveries and their potential for precision medicine. Lancet Rheumatol. 2021, 3, e383–e392. [Google Scholar] [CrossRef]
  23. Clauw, D.J. From fibrositis to fibromyalgia to nociplastic pain: How rheumatology helped get us here and where do we go from here? Ann. Rheum. Dis. 2024, 83, 1421–1427. [Google Scholar] [CrossRef] [PubMed]
  24. Fang, W.; Liu, Y.; Wang, L. Multisensory Integration in Body Representation. Adv. Exp. Med. Biol. 2024, 1437, 77–89. [Google Scholar] [CrossRef] [PubMed]
  25. Shimada, S. Multisensory and Sensorimotor Integration in the Embodied Self: Relationship between Self-Body Recognition and the Mirror Neuron System. Sensors 2022, 22, 5059. [Google Scholar] [CrossRef]
  26. Bremner, A.J. Developing body representations in early life: Combining somatosensation and vision to perceive the interface between the body and the world. Dev. Med. Child Neurol. 2016, 58 (Suppl. 4), 12–16. [Google Scholar] [CrossRef]
  27. Gauduel, T.; Blondet, C.; Gonzalez-Monge, S.; Bonaiuto, J.; Gomez, A. Alteration of body representation in typical and atypical motor development. Dev. Sci. 2024, 27, e13455. [Google Scholar] [CrossRef] [PubMed]
  28. Melillo, R.; Leisman, G.; Machado, C.; Machado-Ferrer, Y.; Chinchilla-Acosta, M.; Kamgang, S.; Melillo, T.; Carmeli, E. Retained Primitive Reflexes and Potential for Intervention in Autistic Spectrum Disorders. Front. Neurol. 2022, 13, 922322. [Google Scholar] [CrossRef]
  29. Patel, D.R.; Bovid, K.M.; Rausch, R.; Ergun-Longmire, B.; Goetting, M.; Merrick, J. CP in children: A clinical practice review. Curr. Probl. Pediatr. Adolesc. Health Care 2024, 54, 101673. [Google Scholar] [CrossRef]
  30. Krägeloh-Mann, I.; Horber, V. The role of magnetic resonance imaging in elucidating the pathogenesis of CP: A systematic review. Dev. Med. Child Neurol. 2007, 49, 144–151. [Google Scholar] [CrossRef]
  31. Jacobs, N.P.T.; Pouwels, P.J.W.; van der Krogt, M.M.; Meyns, P.; Zhu, K.; Nelissen, L.; Schoonmade, L.J.; Buizer, A.I.; van de Pol, L.A. Brain structural and functional connectivity and network organization in CP: A scoping review. Dev. Med. Child Neurol. 2023, 65, 1157–1173. [Google Scholar] [CrossRef]
  32. Laube, W. Bewegungsmangel: Dekonditionierung, Krankheit, Schmerzen, Alter; Springer: Berlin/Heidelberg, Germany, 2023. [Google Scholar]
  33. Laube, W. (Hrsg): Sensomotorisches System; Thieme: Stuttgart, Germany; New York, NY, USA, 2009. [Google Scholar]
  34. Mailleux, L.; Simon-Martinez, C.; Radwan, A.; Blommaert, J.; Gooijers, J.; Wenderoth, N.; Klingels, K.; Ortibus, E.; Sunaert, S.; Feys, H. White matter characteristics of motor, sensory and interhemispheric tracts underlying impaired upper limb function in children with unilateral CP. Brain Struct. Funct. 2020, 225, 1495–1509. [Google Scholar] [CrossRef]
  35. Holmström, L.; Vollmer, B.; Tedroff, K.; Islam, M.; Persson, J.K.; Kits, A.; Forssberg, H.; Eliasson, A.C. Hand function in relation to brain lesions and corticomotor-projection pattern in children with unilateral CP. Dev. Med. Child Neurol. 2010, 52, 145–152. [Google Scholar] [CrossRef] [PubMed]
  36. Scheck, S.M.; Pannek, K.; Fiori, S.; Boyd, R.N.; Rose, S.E. Quantitative comparison of cortical and deep grey matter in pathological subtypes of unilateral CP. Dev. Med. Child Neurol. 2014, 56, 968–975. [Google Scholar] [CrossRef]
  37. Scheck, S.M.; Boyd, R.N.; Rose, S.E. New insights into the pathology of white matter tracts in CP from diffusion magnetic resonance imaging: A systematic review. Dev. Med. Child Neurol. 2012, 54, 684–696. [Google Scholar] [CrossRef] [PubMed]
  38. Lee, D.; Pae, C.; Lee, J.D.; Park, E.S.; Cho, S.R.; Um, M.H.; Lee, S.K.; Oh, M.K.; Park, H.J. Analysis of structure-function network decoupling in the brain systems of spastic diplegic CP. Hum. Brain Mapp. 2017, 38, 5292–5306. [Google Scholar] [CrossRef]
  39. Mailleux, L.; Franki, I.; Emsell, L.; Peedima, M.L.; Fehrenbach, A.; Feys, H.; Ortibus, E. The relationship between neuroimaging and motor outcome in children with CP: A systematic review-Part B diffusion imaging and tractography. Res. Dev. Disabil. 2020, 97, 103569. [Google Scholar] [CrossRef]
  40. Tsao, H.; Pannek, K.; Boyd, R.N.; Rose, S.E. Changes in the integrity of thalamocortical connections are associated with sensorimotor deficits in children with congenital hemiplegia. Brain Struct. Funct. 2015, 220, 307–318. [Google Scholar] [CrossRef]
  41. Ballester-Plané, J.; Schmidt, R.; Laporta-Hoyos, O.; Junqué, C.; Vázquez, É.; Delgado, I.; Zubiaurre-Elorza, L.; Macaya, A.; Póo, P.; Toro, E.; et al. Whole-brain structural connectivity in dyskinetic CP and its association with motor and cognitive function. Hum. Brain Mapp. 2017, 38, 4594–4612. [Google Scholar] [CrossRef] [PubMed]
  42. Caldú, X.; Reid, L.B.; Pannek, K.; Fripp, J.; Ballester-Plané, J.; Leiva, D.; Boyd, R.N.; Pueyo, R.; Laporta-Hoyos, O. Tractography of sensorimotor pathways in dyskinetic CP: Association with motor function. Ann. Clin. Transl. Neurol. 2024, 11, 2609–2622. [Google Scholar] [CrossRef]
  43. Hebert, J.R.; Filley, C.M. Multisensory integration and white matter pathology: Contributions to cognitive dysfunction. Front. Neurol. 2022, 13, 1051538. [Google Scholar] [CrossRef]
  44. Laporta-Hoyos, O.; Pannek, K.; Ballester-Plané, J.; Reid, L.B.; Vázquez, É.; Delgado, I.; Zubiaurre-Elorza, L.; Macaya, A.; Póo, P.; Meléndez-Plumed, M.; et al. White matter integrity in dyskinetic CP: Relationship with intelligence quotient and executive function. Neuroimage Clin. 2017, 12, 789–800. [Google Scholar] [CrossRef]
  45. Saini, A.G.; Sankhyan, N.; Malhi, P.; Ahuja, C.; Khandelwal, N.; Singhi, P. Dyskinetic CP in Children: Clinical Perspectives on Common Comorbidities and Health-Related Quality of Life. J. Autism Dev. Disord. 2024. [Google Scholar] [CrossRef]
  46. Ding, J.Y.; Cleary, S.L.; Morgan, P.E. Health literacy (Gesundheitskompetenz) in adolescents and young adults with CP: A mixed methods systematic review. Disabil. Rehabil. 2024, 46, 5717–5729. [Google Scholar] [CrossRef]
  47. IASP. Terminology International Association for the Study of Pain. Available online: https://www.iasp-pain.org/resources/terminology/ (accessed on 8 February 2025).
  48. Finnerup, N.B.; Haroutounian, S.; Kamerman, P.; Baron, R.; Bennett, D.L.H.; Bouhassira, D.; Cruccu, G.; Freeman, R.; Hansson, P.; Nurmikko, T.; et al. Neuropathic pain: An updated grading system for research and clinical practice. Pain 2016, 157, 1599–1606. [Google Scholar] [CrossRef] [PubMed]
  49. Cohen, M.; Quintner, J.; Weisman, A. “Nociplastic Pain”: A Challenge to Nosology and to Nociception. J. Pain 2023, 12, 2131–2139. [Google Scholar] [CrossRef]
  50. Nijs, J.; Kosek, E.; Chiarotto, A.; Cook, C.; Danneels, L.A.; Fernández-de-Las-Peñas, C.; Hodges, P.W.; Koes, B.; Louw, A.; Ostelo, R.; et al. Nociceptive, neuropathic, or nociplastic low back pain? The low back pain phenotyping (BACPAP) consortium’s international and multidisciplinary consensus recommendations. Lancet Rheumatol. 2024, 6, e178–e188. [Google Scholar] [CrossRef] [PubMed]
  51. Peterson, M.D.; Haapala, H.; Kamdar, N.; Lin, P.; Hurvitz, E.A. Pain phenotypes among adults living with CP and spina bifida. Pain 2021, 162, 2532–2538. [Google Scholar] [CrossRef]
  52. Heinen, F.; Bonfert, M.; Kaňovský, P.; Schroeder, A.S.; Chambers, H.G.; Dabrowski, E.; Geister, T.L.; Hanschmann, A.; Althaus, M.; Banach, M.; et al. Spasticity-related pain in children/adolescents with CP. Part 1: Prevalence and clinical characteristics from a pooled analysis. J. Pediatr. Rehabil. Med. 2022, 15, 129–143. [Google Scholar] [CrossRef] [PubMed]
  53. Peterson, M.D.; Haapala, H.J.; Kratz, A. Pain Phenotypes in Adults Living With CP. Neurol. Clin. Pract. 2021, 11, e848–e855. [Google Scholar] [CrossRef]
  54. Jarlman, E.; Hägglund, G.; Alriksson-Schmidt, A.I. Foot and lower leg pain in children and adults with CP: A population-based register study on 5,122 individuals. BMC Musculoskelet. Disord. 2024, 25, 391. [Google Scholar] [CrossRef]
  55. Yoo, Y.M.; Kim, K.H. Current understanding of nociplastic pain. Korean J. Pain 2024, 37, 107–118. [Google Scholar] [CrossRef]
  56. Kaplan, C.M.; Kelleher, E.; Irani, A.; Schrepf, A.; Clauw, D.J.; Harte, S.E. Deciphering nociplastic pain: Clinical features, risk factors and potential mechanisms. Nat. Rev. Neurol. 2024, 20, 347–363. [Google Scholar] [CrossRef]
  57. Bułdyś, K.; Górnicki, T.; Kałka, D.; Szuster, E.; Biernikiewicz, M.; Markuszewski, L.; Sobieszczańska, M. What Do We Know about Nociplastic Pain? Healthcare 2023, 11, 1794. [Google Scholar] [CrossRef]
  58. Wirth, B.; Schweinhardt, P. Personalized assessment and management of non-specific low back pain. Eur. J. Pain 2024, 28, 181–198. [Google Scholar] [CrossRef]
  59. Handsfield, G.G.; Williams, S.; Khuu, S.; Lichtwark, G.; Stott, N.S. Muscle architecture, growth, and biological remodelling in CP: A narrative review. BMC Musculoskelet. Disord. 2022, 23, 233. [Google Scholar] [CrossRef] [PubMed]
  60. Schless, S.H.; Cenni, F.; Bar-On, L.; Hanssen, B.; Goudriaan, M.; Papageorgiou, E.; Aertbeliën, E.; Molenaers, G.; Desloovere, K. Combining muscle morphology and neuromotor symptoms to explain abnormal gait at the ankle joint level in CP. Gait Posture 2019, 68, 531–537. [Google Scholar] [CrossRef] [PubMed]
  61. Hanssen, B.; Peeters, N.; Vandekerckhove, I.; De Beukelaer, N.; Bar-On, L.; Molenaers, G.; Van Campenhout, A.; Degelaen, M.; Van den Broeck, C.; Calders, P.; et al. The Contribution of Decreased Muscle Size to Muscle Weakness in Children with Spastic CP. Front. Neurol. 2021, 12, 692582. [Google Scholar] [CrossRef] [PubMed]
  62. Laube, W. Die Muskulatur—Das „signalstoffgestützte periphere Zentrum“ adaptiver Wirkungen. Man. Med. 2022, 60, 104–106. [Google Scholar] [CrossRef]
  63. Haapala, H.J.; Schmidt, M.; Lin, P.; Kamdar, N.; Mahmoudi, E.; Peterson, M.D. Musculoskeletal Morbidity Among Adults Living With Spina Bifida and CP. Top. Spinal Cord Inj. Rehabil. 2022, 28, 73–84. [Google Scholar] [CrossRef] [PubMed]
  64. Harvey, A.; Smith, N.; Smith, M.; Ostojic, K.; Berryman, C. Chronic pain in children and young people with CP: A narrative review of challenges, advances, and future directions. BMC Med. 2024, 22, 238. [Google Scholar] [CrossRef]
  65. Carozza, L.; Anderson-Mackay, E.; Blackmore, A.M.; Kirkman, H.A.; Ou, J.; Smith, N.; Love, S. Chronic Pain in Young People With CP: Activity Limitations and Coping Strategies. Pediatr. Phys. Ther. 2022, 34, 489–495. [Google Scholar] [CrossRef]
  66. Lee, J.; Protsenko, E.; Lazaridou, A.; Franceschelli, O.; Ellingsen, D.M.; Mawla, I.; Isenburg, K.; Berry, M.P.; Galenkamp, L.; Loggia, M.L.; et al. Encoding of Self-Referential Pain Catastrophizing in the Posterior Cingulate Cortex in Fibromyalgia. Arthritis Rheumatol. 2018, 70, 1308–1318. [Google Scholar] [CrossRef]
  67. Blackman, J.A.; Svensson, C.I.; Marchand, S. Pathophysiology of chronic pain in CP: Implications for pharmacological treatment and research. Dev. Med. Child Neurol. 2018, 60, 861–865. [Google Scholar] [CrossRef] [PubMed]
  68. Malfliet, A.; Coppieters, I.; Van Wilgen, P.; Kregel, J.; De Pauw, R.; Dolphens, M.; Ickmans, K. Brain changes associated with cognitive and emotional factors in chronic pain: A systematic review. Eur. J. Pain 2017, 21, 769–786. [Google Scholar] [CrossRef] [PubMed]
  69. Wirtz, M.A. (Hrsg.): Dorsch—Lexikon der Pscyhologie; Hofgrebe AG: Bern, Switzerland, 2022. [Google Scholar]
  70. Rose, J.; McGill, K.C. The motor-unit in CP. Dev. Med. Child Neurol. 1998, 40, 270–277. [Google Scholar] [CrossRef]
  71. Noble, J.J.; Gough, M.; Shortland, A.P. Selective motor control and gross motor function in bilateral spastic CP. Dev. Med. Child Neurol. 2019, 61, 57–61. [Google Scholar] [CrossRef] [PubMed]
  72. Aisen, M.L.; Kerkovich, D.; Mast, J.; Mulroy, S.; Wren, T.A.; Kay, R.; Rethlefsen, S.A. CP: Clinical care and neurological rehabilitation. Lancet Neurol. 2011, 10, 844–852. [Google Scholar] [CrossRef]
  73. Vitrikas, K.; Dalton, H.; Breish, D. CP: An Overview. Am. Fam. Physician 2020, 101, 213–220. [Google Scholar]
  74. Devesa, J.; Casteleiro, N.; Rodicio, C.; López, N.; Reimunde, P. Growth hormone deficiency and CP. Ther. Clin. Risk Manag. 2010, 6, 413–418. [Google Scholar] [CrossRef]
  75. Hegazi, M.A.; Soliman, O.E.; Hasaneen, B.M.; El-Arman, M.; El-Galel, N.A.; El-Deek, B.S. Growth hormone/insulin-like growth factor-1 axis: A possible non-nutritional factor for growth retardation in children with CP. J. Pediatr. 2012, 88, 267–274. [Google Scholar] [CrossRef]
  76. Hoon, A.H.; Stashinko, E.E.; Nagae, L.M.; Lin, D.D.M.; Keller, J.; Bastian, A.; Campell, M.L.; Levey, E.; Mori, S.; Johnston, M.V. Sensory and motor deficits in children with CP born preterm correlate with diffusion tenso imaging abnormalities in thalamocortical pathways. Dev. Med. Child Neurol. 2009, 51, 697–704. [Google Scholar] [CrossRef]
  77. Fridèn, J.; Lieber, R.L. Spastic muscle cells are shorter and stiffer than normal cells. Muscle Nerve 2003, 27, 157–164. [Google Scholar] [CrossRef] [PubMed]
  78. Bax, M.; Tydeman, C.; Flodmark, O. Clinical and MRI correlates for CP: The European CP Study. JAMA 2006, 296, 1602–1608. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.